Forecast & Rating4 analysts currently cover Amneal Pharmaceuticals, of which 4 give a positive rating. The average price target is $20.75, about 16.7% upside from the current price of $17.78. Coverage is limited, so the data is for reference only. Data as of Aug 3, 2026; this does not constitute investment advice.
Aug 3, 2026Price forecast
$20.7516.70%
Forecast & RatingBuy
4analysts
- Strong buy50.00%
- Buy50.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 23, 2026
Forecast met67.0%
Stock price$17.78
Avg. target$14.0
High target$15
Low target$13
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.